Cardiac allograft vasculopathy diagnosed by vasodilator myocardial contrast echocardiography perfusion imaging.
Pooja PrasadRaj NagappanBrian P DavidsonKevin WeiJames HodovanJonathan R LindnerJohannes SteinerPublished in: ESC heart failure (2023)
Cardiac allograft vasculopathy (CAV) remains a common long-term complication of cardiac transplantation. While invasive coronary angiography is considered the gold standard, it is also invasive and lacks sensitivity to detect early, distal CAV. Although vasodilator stress myocardial contrast echocardiography perfusion imaging (MCE) is used in the detection of microvascular disease in non-transplant patients, there is little data guiding its use in transplant recipients. Herein is a case series of four heart transplant recipients that had vasodilator stress MCE performed in addition to invasive coronary angiography for CAV surveillance. MCE at rest and after regadenason was performed using a continuous infusion of lipid-shelled microbubbles. We describe a case of normal microvascular function, diffuse microvascular dysfunction, patchy sub-endocardial perfusion defects and a focal sub-endocardial perfusion defect. Cardiac allograft vasculopathy can be heralded by several different perfusion patterns on MCE in patients after orthotopic heart transplant. The varying prognoses and potential interventions for these different patterns require further investigation.
Keyphrases
- left ventricular
- contrast enhanced
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- high resolution
- magnetic resonance
- computed tomography
- peritoneal dialysis
- prognostic factors
- low dose
- magnetic resonance imaging
- atrial fibrillation
- kidney transplantation
- patient reported
- stress induced
- loop mediated isothermal amplification
- heat stress
- cell therapy